Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
After-Hours: 20:00
Adaptive Biotechnologies Max Drawdown (5Y) : 96.55% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.55% |
| August 31, 2026 | 96.55% |
| July 31, 2026 | 96.55% |
| June 30, 2026 | 96.55% |
| May 31, 2026 | 96.55% |
| April 30, 2026 | 96.55% |
| March 31, 2026 | 96.55% |
| February 28, 2026 | 96.55% |
| January 31, 2026 | 96.55% |
| December 31, 2025 | 96.55% |
| November 30, 2025 | 96.55% |
| October 31, 2025 | 96.55% |
| September 30, 2025 | 96.55% |
| August 31, 2025 | 96.55% |
| July 31, 2025 | 96.55% |
| June 30, 2025 | 96.55% |
| May 31, 2025 | 96.55% |
| April 30, 2025 | 96.55% |
| March 31, 2025 | 96.55% |
| February 28, 2025 | 96.55% |
| January 31, 2025 | 96.55% |
| December 31, 2024 | 96.55% |
| November 30, 2024 | 96.55% |
| October 31, 2024 | 96.55% |
| September 30, 2024 | 96.55% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.55% |
| July 31, 2024 | 96.55% |
| June 30, 2024 | 96.55% |
| May 31, 2024 | 96.55% |
| April 30, 2024 | 96.55% |
| March 31, 2024 | 95.75% |
| February 29, 2024 | 94.90% |
| January 31, 2024 | 94.90% |
| December 31, 2023 | 94.90% |
| November 30, 2023 | 94.90% |
| October 31, 2023 | 93.98% |
| September 30, 2023 | 92.52% |
| August 31, 2023 | 91.08% |
| July 31, 2023 | 91.08% |
| June 30, 2023 | 90.86% |
| May 31, 2023 | 90.86% |
| April 30, 2023 | 90.76% |
| March 31, 2023 | 90.76% |
| February 28, 2023 | 90.76% |
| January 31, 2023 | 90.76% |
| December 31, 2022 | 90.76% |
| November 30, 2022 | 90.76% |
| October 31, 2022 | 90.76% |
| September 30, 2022 | 90.55% |
| August 31, 2022 | 90.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Personalis, Inc. | 98.18% |
| 10X Genomics, Inc. | 96.47% |
| Alamar Biosciences, Inc. (California) | -- |
| Champions Oncology, Inc. | 78.53% |
| Medpace Holdings, Inc. | 42.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -27.93 |
| Beta (5Y) | 2.094 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.98% |
| Historical Sharpe Ratio (5Y) | -0.1091 |
| Historical Sortino (5Y) | -0.194 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.92% |